GE HealthCare Reports Strong Q1 Performance

GE HealthCare Technologies Inc. announced a notable 3% year-on-year revenue increase to $4.8 billion in the first quarter of fiscal 2025, exceeding market expectations. This growth underscores the company's robust operational execution and strategic focus.

Financial Highlights

The company's net income saw a significant 50.8% jump compared to the same quarter in 2024, reaching $564 million. Diluted earnings per share (EPS) also experienced a remarkable 51.85% annual increase to $1.23. In a move to return value to shareholders, GE HealthCare unveiled a $1 billion share repurchase program.

Strategic Moves and Future Outlook

"Our first quarter results demonstrate strong execution, with robust revenue, orders, and profit growth, particularly in the U.S. We are committed to advancing our precision care and growth acceleration strategies, highlighted by our recent acquisition of Nihon Medi-Physics. This acquisition is expected to enhance global access to our next-generation radiopharmaceuticals," stated CEO Peter Arduini.

Following the earnings report, GE HealthCare's stock price rose by 2.81% in premarket trading, reaching $70 per share at 6:29 am ET.